Stock Events

Stock Events

Neoleukin Therapeutics 

$3.49
14
+$0.05+1.45% Monday 21:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
148.6M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

18MarExpected
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.41
-0.29
-0.16
-0.04
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
0Revenue
-57.56MNet Income

Analyst Ratings

$106.67Average Price Target
The highest estimate is 200.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NLTX. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Health Technology
Biotechnology
Pharmaceuticals: Major
Manufacturing
Pharmaceutical Preparation Manufacturing
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aquinox Pharmaceuticals, Inc. and changed its name to Neoleukin Therapeutics, Inc. in August 2019. Neoleukin Therapeutics, Inc. was founded in 2003 and is headquartered in Seattle, Washington.
Show more...
CEO
Employees
79
Country
US
ISIN
US64049K1043

Listings

F
DE
UU8.F
XNAS
US
NGNE
BOATS
BOATS
NGNE.BOATS

0 Comments

Share your thoughts

FAQ

What is Neoleukin Therapeutics stock price today?▼
The current price of NLTX is $3.49 USD — it has increased by +1.45% in the past 24 hours. Watch Neoleukin Therapeutics stock price performance more closely on the chart.
What is Neoleukin Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Neoleukin Therapeutics stocks are traded under the ticker NLTX.
What is Neoleukin Therapeutics market cap?▼
Today Neoleukin Therapeutics has the market capitalization of 148.6M
What is Neoleukin Therapeutics revenue for the last year?▼
Neoleukin Therapeutics revenue for the last year amounts to 0 USD.
What is Neoleukin Therapeutics net income for the last year?▼
NLTX net income for the last year is -57.56M USD.
How many employees does Neoleukin Therapeutics have?▼
As of April 05, 2026, the company has 79 employees.
In which sector is Neoleukin Therapeutics located?▼
Neoleukin Therapeutics operates in the Manufacturing sector.
When did Neoleukin Therapeutics complete a stock split?▼
The last stock split for Neoleukin Therapeutics was on December 19, 2023 with a ratio of 1:4.